BRIEF-Celon Pharma Files Marketing Authorization Applications In EU For Semaglutide Drug Injection Solution

3

Oct 16 (Reuters) – Celon Pharma SA: * FILES MARKETING AUTHORIZATION APPLICATIONS IN EU FOR SEMAGLUTIDE DRUG INJECTION SOLUTION * GERMANY AND AUSTRIA TO SERVE AS REFERENCE STATES UNDER APPLICATION

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)